Evidence map›Paper›PMID 33204335›Full record

ArticleTheranostics2020

Xinglu Jiang, Xiaobo Fan, Rui Zhang, Wei Xu, Hailu Wu, Fengfeng Zhao, Han Xiao, Chen Zhang, Chenggui Zhao, Guoqiu Wu

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. HNanoscale research letters · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xinglu JiangMedical School of Southeast University, Nanjing 210009, People's Republic of China.
Xiaobo FanMedical School of Southeast University, Nanjing 210009, People's Republic of China.
Rui ZhangMedical School of Southeast University, Nanjing 210009, People's Republic of China.
Wei XuMedical School of Southeast University, Nanjing 210009, People's Republic of China.
Hailu WuMedical School of Southeast University, Nanjing 210009, People's Republic of China.
Fengfeng ZhaoCenter of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, People's Republic of China.
Han XiaoMedical School of Southeast University, Nanjing 210009, People's Republic of China.
Chen ZhangCenter of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, People's Republic of China.
Chenggui ZhaoCenter of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, People's Republic of China.
Guoqiu WuCenter of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, People's Republic of China.
Southeast University · CNZhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic Combined Chemotherapy ProtocolsCell HypoxiaCell Line, TumorCell MembraneCell Membrane PermeabilityCell NucleusDoxorubicinDrug Delivery SystemsDrug LiberationHumansHydrogen-Ion ConcentrationIndocyanine GreenNanoparticlesNeoplasmsParticle SizeDoxorubicinIndocyanine GreenPeptidespirarubicindrug combination therapyself-assembling peptidesize and charge switches.subcellular drug deliverytriggered drug release

Identifiers

PMID33204335
PMCPMC7667678
OpenAlexW3097095313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.